PT
Platform Therapeutics, Inc.
SEC filingBiotechnology · Andover, MA
Amount raised$1.8Msold at filing
Total offering$4M$2.3M still open
Investors in the raise1count reported to the SEC
FiledAug 27, 2026first sale Aug 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
JAMES WILKIEExecutive Officer, Director
LAKHMIR CHAWLADirector
Executive officers, directors and promoters as listed on the Form D.